Edition:
United States

Keryx Biopharmaceuticals Inc (KERX.PH)

KERX.PH on Philadelphia Stock Exchange

6.46USD
26 May 2017
Change (% chg)

$0.04 (+0.62%)
Prev Close
$6.42
Open
$6.42
Day's High
$6.52
Day's Low
$6.40
Volume
3,463
Avg. Vol
9,798
52-wk High
$7.79
52-wk Low
$4.04

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.18 December 27 May 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 3 3 3 3
(3) HOLD 5 5 5 5
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.44 2.44 2.44 2.44

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-17 7 14.51 15.42 13.47 18.32
Quarter Ending Sep-17 7 17.66 19.00 16.80 19.92
Year Ending Dec-17 8 64.88 67.00 62.70 90.47
Year Ending Dec-18 8 129.02 185.70 95.48 169.39
Earnings (per share)
Quarter Ending Jun-17 8 -0.18 -0.13 -0.21 -0.06
Quarter Ending Sep-17 8 -0.16 -0.11 -0.19 -0.05
Year Ending Dec-17 8 -0.69 -0.52 -0.80 -0.31
Year Ending Dec-18 7 -0.23 -0.10 -0.32 0.13

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-17 10.29 11.82 1.53 14.88
Quarter Ending Dec-16 8.41 9.53 1.12 13.30
Quarter Ending Sep-16 5.45 6.34 0.89 16.33
Quarter Ending Jun-16 8.57 9.29 0.72 8.35
Quarter Ending Mar-16 6.64 6.82 0.19 2.81
Earnings (per share)
Quarter Ending Mar-17 -0.20 -0.21 0.01 -3.86
Quarter Ending Dec-16 -0.25 -0.32 0.07 -28.00
Quarter Ending Sep-16 -0.20 -0.39 0.19 -91.83
Quarter Ending Jun-16 -0.28 -0.42 0.14 -52.73
Quarter Ending Mar-16 -0.26 -0.39 0.13 -52.64

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-17 14.51 14.51 12.23 12.09 18.32
Quarter Ending Sep-17 17.66 17.66 14.16 14.01 19.92
Year Ending Dec-17 64.88 64.88 55.29 55.00 90.47
Year Ending Dec-18 129.02 129.02 124.92 124.89 169.39
Earnings (per share)
Quarter Ending Jun-17 -0.18 -0.18 -0.19 -0.19 -0.06
Quarter Ending Sep-17 -0.16 -0.16 -0.17 -0.17 -0.05
Year Ending Dec-17 -0.69 -0.69 -0.66 -0.67 -0.31
Year Ending Dec-18 -0.23 -0.23 -0.25 -0.25 0.13

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-17 0 0 7 0
Quarter Ending Sep-17 0 0 7 0
Year Ending Dec-17 0 0 8 0
Year Ending Dec-18 0 0 4 2
Earnings
Quarter Ending Jun-17 0 0 3 4
Quarter Ending Sep-17 0 0 6 2
Year Ending Dec-17 0 0 4 3
Year Ending Dec-18 0 0 5 2

More From Around the Web